Clinical and cellular phenotypes associated with sequestosome 1 (SQSTM1) mutations

Journal of Bone and Mineral Research

Volumn 21, Issue SUPPL. 2, 2006, Pages

  Leach, Robin J ^a   Singer, Frederick R ^b   Ench, Yasmin ^a   Wisdom, Julie H ^a   Pina, Diana S ^a   Johnson Pais, Teresa L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

incomplete penetrance; mutation; phenotypes; predisposition gene; sequestosome 1

Indexed keywords

EID: 33846504404     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1359/jbmr.06s208     Document Type: Conference Paper

References (20)

1. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, Shanks CA, Gregg G, Al-Lozi MT, Miller T, Rakowica W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, Pestronk A, Kimonis VE, 2001 Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74: 458-475. (Pubitemid 34084655)
2. Hughes AE, Ralston ST, Marker J, Bell C, MacPherson H, Wallace RGH, van Hul W, Whyte MP, Nakatsuka K, Hovey L, Anderson DM, 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24: 45-48. (Pubitemid 30041418)
3. Laurin N, Brown JP, Lemainque A, Duschesne A, Huot D, Lacourciere Y, Drapeu G, Verreault J, Raymond V, Morissette J, 2001 Paget disease of bone: Mapping of two loci on 5q35-qter and 5q31. Am J Hum Genet 69: 528-543. (Pubitemid 32777692)
4. Laurin N, Brown JP, Morissette J, Raymond V, 2002 Recurrent mutation in the gene encoding sequestosome 1 (SQSTM!/p62) in Paget disease of bone. Am J Hum Genet 70: 1582-1588. (Pubitemid 34533906)
5. Hocking LJ, Lucas GJA, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Suyts W, Van Hul W, Ralston SH, 2002 Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11: 2735-2739. (Pubitemid 35214900)
6. Eekhoff EWM, Karperien M, Houtsma D, Zwinderman AH, Dragoiescu C, Kneppers ALJ, Papaouls SE, 2004 Familial Paget's disease in the Netherlands. Arthritis Rheum 50: 1650-1654.
7. Leach RJ, Singer FR, Cody JD, Roodman GD, 1999 Variable disease severity associated with a Paget's disease predisposition gene. J Bone Miner Res 14: 17-20. (Pubitemid 29455793)
8. Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singer FR, Leach RJ, 2003 Three novel mutations in SQSTM1 identified in familial Paget's disease of the bone. J Bone Miner Res 18: 1748-1753. (Pubitemid 37322550)
9. Sanchez P, DeCarcer G, Sandoval IV, Moscat J, Diaz-Meco MT, 1998 Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol 18: 3069-3080. (Pubitemid 28183475)
10. Shin J, 1998 P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res 21: 629-633. (Pubitemid 128668388)
11. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MA, 2004 Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 24: 8055-8068. (Pubitemid 39167456)
12. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T, 2005 p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614. (Pubitemid 41668720)
13. Wilson MI, Gill DJ, Perisic O, Quinn MT, Williams R, 2003 PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol Cell Biol 12: 39-50. (Pubitemid 36957832)
14. Lamark T, Perander M, Outzen H, Kristiansen K, Overvatn A, Michaelson E, Bjorkoy G, Johansen T, 2003 Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J Biol Chem 278: 34568-34581. (Pubitemid 37553306)
15. Falchetti A, Di Stefano M, Marini F, Del Monte F, Gozzini A, Masi L, Tanini A, Amdeei A, Carossino A, Isaia G, Brandi ML, 2005 Segregation of a M404V mutation of the p62/sequestosome1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family. Arthrit Res Ther 7: R1289-R1295.
16. Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH, 2004 Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: Genotype phenotype correlations, functional analysis and structural consequences. J Bone Miner Res 19: 1122-1127. (Pubitemid 41110564)
17. Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS, Layfield R, 2005 Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 20: 619-624. (Pubitemid 40393070)
18. Pickart CM, 2001 Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533. (Pubitemid 32663902)
19. Cavey JR, Ralston SH, Sheppard PW, Ciani B, Gallagher TRA, Long JE, Searle MS, Layfield R, 2006 Loss of ubiquiting binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone. Calcif Tissue Int 78: 271-277. (Pubitemid 43725186)
20. Wooten MW, Geetha T, Seinbenhener ML, Baby JR, Diaz-Meco MT, Moscat J, 2005 The p62 scaffold regulates nerve growth factor-induced NF-κB activation by influencing TRAF6 polyubiquitination. J Biol Chem 280: 35625-35629. (Pubitemid 41532755)